CommercialCoverageMedium impact
PAP309 - Drug Screening/Testing for Pain Management and Substance Use Disorder Treatment - New
Blue Cross of Idaho·ID · Pain Management, Psychiatry, Family Medicine +1 more·Pharmacy
We identified it
Jun 19, 2026
Summary
Blue Cross of Idaho has issued a new policy PAP309 regarding drug screening and testing procedures for pain management and substance use disorder treatment. This policy establishes coverage guidelines and billing requirements for drug testing in these specific clinical scenarios.
Action Required
Immediately: Review the full PAP309 policy at https://providers.bcidaho.com/policies-and-procedures/pap/pap309.page to understand specific coverage requirements and billing guidelines for drug screening/testing in pain management and substance use disorder treatment. Update billing procedures and staff training accordingly for Blue Cross of Idaho patients.